Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jawed Fareed

Showing results (281-290 of 393) with videos related to

Pageof 40
Sort By:
Critical Care Medicine|July 23, 2020
Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated CoagulopathyMarcel Levi, Jean-Louis Vincent, Kosuke Tanaka, et al.
Molecular and Cellular Biochemistry|March 20, 2004
Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesisSarfraz Ahmad, Brian Untch, Sylvia Haas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 19, 2022
Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary EmbolismIman Darwish, Jawed Fareed, Yevgeniy Brailovsky, et al.
Current Pharmaceutical Design|May 17, 2007
Heparin oligosaccharides as potential therapeutic agents in senile dementiaQing Ma, Umberto Cornelli, Israel Hanin, et al.
Biochemical Pharmacology|April 25, 2009
Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparinsBoyangzi Li, Jiraporn Suwan, Jeffrey G Martin, et al.
Thrombosis Research|August 17, 2002
Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodiesBrian Untch, Sarfraz Ahmad, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 30, 2018
Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial FibrillationJack Bontekoe, Justin Lee, Vinod Bansal, et al.
Archives of Pathology & Laboratory Medicine|April 24, 2003
Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patientsSarfraz Ahmad, H Peter Bacher, Michael R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 2, 2021
Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip ReplacementPeter Poredos, Pavel Poredos, Mateja K Jezovnik, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 15, 2021
Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot SurveyBulent Kantarcioglu, Krishan Patel, Joseph Lewis, et al.
Pageof 40

Showing results (281-290 of 393) with videos related to

Sort By:
Pageof 40
Critical Care Medicine|July 23, 2020
Effect of a Recombinant Human Soluble Thrombomodulin on Baseline Coagulation Biomarker Levels and Mortality Outcome in Patients With Sepsis-Associated CoagulopathyMarcel Levi, Jean-Louis Vincent, Kosuke Tanaka, et al.
Molecular and Cellular Biochemistry|March 20, 2004
Differential prevalence of anti-heparin-PF4 immunoglobulin subtypes in patients treated with clivarin and heparin: implications in the HIT pathogenesisSarfraz Ahmad, Brian Untch, Sylvia Haas, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|January 19, 2022
Dysregulation of Biomarkers of Hemostatic Activation and Inflammatory Processes are Associated with Adverse Outcomes in Pulmonary EmbolismIman Darwish, Jawed Fareed, Yevgeniy Brailovsky, et al.
Current Pharmaceutical Design|May 17, 2007
Heparin oligosaccharides as potential therapeutic agents in senile dementiaQing Ma, Umberto Cornelli, Israel Hanin, et al.
Biochemical Pharmacology|April 25, 2009
Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparinsBoyangzi Li, Jiraporn Suwan, Jeffrey G Martin, et al.
Thrombosis Research|August 17, 2002
Development of a non-human primate sub-clinical model of heparin-induced thrombocytopenia: platelet responses to human anti-heparin-platelet factor 4 antibodiesBrian Untch, Sarfraz Ahmad, Harry L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 30, 2018
Biomarker Profiling in Stage 5 Chronic Kidney Disease Identifies the Relationship between Angiopoietin-2 and Atrial FibrillationJack Bontekoe, Justin Lee, Vinod Bansal, et al.
Archives of Pathology & Laboratory Medicine|April 24, 2003
Investigations of the immunoglobulin subtype transformation of anti-heparin-platelet factor 4 antibodies during treatment with a low-molecular-weight heparin (clivarin) in orthopedic patientsSarfraz Ahmad, H Peter Bacher, Michael R Lassen, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 2, 2021
Time Course of Inflammatory and Procoagulant Markers in the Early Period After Total Hip ReplacementPeter Poredos, Pavel Poredos, Mateja K Jezovnik, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 15, 2021
Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot SurveyBulent Kantarcioglu, Krishan Patel, Joseph Lewis, et al.
Pageof 40